Skip to main content
. 2021 May 10;13(9):2274. doi: 10.3390/cancers13092274

Figure 1.

Figure 1

Liquid biopsy is the molecular analysis of cancer by-products released in the bloodstream. Novel potential biomarkers are represented by circulating nucleic acids, extracellular vesicles (EVs), and circulating tumor cells (CTCs). (Adapted from Labgaa et al. [24]).